Male breast cancer patients should be treated earlier
This article was originally published in Scrip
The earlier treatment of men with breast cancer, particularly with hormone therapy, could improve outcomes, according to a study conducted by the Orion Collaborative Group. The results of the study were presented by the group’s Dr Marina Garassino at the recent European Society for Medical Oncology (ESMO) conference in Lugano, Switzerland.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
The R&D-based lobby group, Medicines Australia, has published a report calling for stakeholders across the Australian healthcare ecosystem to discuss how to “pragmatically address the evidence needs of the future.”
NICE will review new data in deciding whether to ok the use of Spinraza in non-ambulant SMA type III patients.